Liver Fibrosis and Cirrhosis

Dear Colleagues,

Liver fibrosis and cirrhosis are caused by a wide range of chronic liver diseases, including hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, alcoholic-related liver disease, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver diseases. Recent advances in molecular and cellular techniques have succeeded in providing new aspects in the diagnosis and treatment of liver fibrosis and cirrhosis. This Special Issue aims to cover the state-of-the-art researches on the basic and clinical findings in relation to the liver fibrosis and cirrhosis. We invite authors to submit original articles, as well as review articles regarding recent findings about liver fibrosis and cirrhosis. We are particularly interested in molecular approaches for the diagnosis and treatment of chronic liver diseases. Potential topics include, but are not limited to:

• Biomarkers for liver fibrosis/cirrhosis and their complications
• Genomic researches for chronic liver diseases and their complications, including gene SNPs (Single Nucleotide Polymorphisms)
• Molecular mechanisms of liver fibrosis/cirrhosis and their complications
• Recent advances in the management of liver fibrosis and cirrhosis
• Molecularly-targeted therapy for liver cancer

Dr. Hirayuki Enomoto
Dr. Tatsuo Kanda
Topic Editors